WO2006034064A2 - Process for sterilization of and cyanoacrylate adhesive compositions and devices - Google Patents

Process for sterilization of and cyanoacrylate adhesive compositions and devices Download PDF

Info

Publication number
WO2006034064A2
WO2006034064A2 PCT/US2005/033226 US2005033226W WO2006034064A2 WO 2006034064 A2 WO2006034064 A2 WO 2006034064A2 US 2005033226 W US2005033226 W US 2005033226W WO 2006034064 A2 WO2006034064 A2 WO 2006034064A2
Authority
WO
WIPO (PCT)
Prior art keywords
cyanoacrylate
poly
composition
cyanoacrylates
sterilization
Prior art date
Application number
PCT/US2005/033226
Other languages
French (fr)
Other versions
WO2006034064A3 (en
Inventor
Carlos Morales
Original Assignee
Chemence Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemence Inc filed Critical Chemence Inc
Priority to EP05812222A priority Critical patent/EP1807121A4/en
Publication of WO2006034064A2 publication Critical patent/WO2006034064A2/en
Publication of WO2006034064A3 publication Critical patent/WO2006034064A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J4/00—Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
    • C09J4/06—Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups C09J159/00 - C09J187/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/26—Accessories or devices or components used for biocidal treatment
    • A61L2/28—Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/131—Glass, ceramic, or sintered, fused, fired, or calcined metal oxide or metal carbide containing [e.g., porcelain, brick, cement, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]

Definitions

  • TITLE Process for Sterilization of and Cyanoacrylate Adhesive Compositions and Devices
  • the invention relates to compositions of cyanoacrylate monomer and polymer adhesive compositions, a process for sterilizing them for application in the medical and veterinary fields, and a method of assaying the sterilization of cyanoacrylate compositions.
  • 2-cyanoacrylate esters As adhesives for bonding tissue in medical or surgical procedures performed upon the human or animal body. 2-cyanoacrylate esters polymerize rapidly, and often instantaneously, upon contact with tissue or body fluid. In these applications, the adhesive composition can be used to close wounds, as well as for covering and protecting surface injuries such as lacerations, abrasions, burns, sores and other open surface wounds.
  • 2-cyanoacrylates must be sterilized. This is generally done in sealed containers to provide sterility, and from a practical perspective, to protect the compositions from moisture and premature polymerization. Previous sterilization methods involved either the use of ionizing radiation, including e-beam and gamma ray irradiation, dry heat at elevated temperatures (16O o C), or chemical sterilization such as with ethylene oxide.
  • an adhesive composition When an adhesive composition is applied to a surface to be closed or protected, it is usually in its monomeric form, and the resultant polymerization produces the desired adhesive bond.
  • the monomeric form of the adhesive has a low viscosity which results in the adhesive spreading into undesired areas. Therefore, it is desirable to increase the viscosity of the composition to prevent this unwanted flow.
  • thickening agents can be added to the monomeric composition.
  • the present invention is directed to a method of sterilizing 2-cyanoacrylate compositions, including heating the composition in a device at a temperature of from about 7O o C to about 14O o C for an effective amount of time.
  • the invention includes sterilized 2-cyanoacrylate ester compositions for use in medical applications or surgery, the compositions being disposed in sealed aluminum containers and being sterilized at a temperature of between about 7O o C and about 14O o C.
  • the compositions can be disposed in sealed aluminum, tin, stainless steel tubes or pouches or glass containers.
  • the invention is directed to a method for assaying the sterilization of cyanoacrylate compositions.
  • the present invention provides a novel method of sterilizing 2-Cyanoacrylate ester compositions using a dry heat means, and the resulting novel compositions.
  • the combination of monomeric 2-Cyanoacrylate, heat and time have a lethal effect on microbials, rendering sterilized compositions when the appropriate sterilization condition is achieved and when the method is applied to 2-Cyanoacrylates in sealed containers.
  • cyanoacrylate adhesive composition or “cyanoacrylate adhesive compositions” refers to polymerizable formulations comprising polymerizable cyanoacrylate ester monomers.
  • aldose is intended to refer to both common disacharides and monosacharides.
  • 2-cyanoacrylate adhesive compositions are sterilized through an unexpected and heretofore unknown combination of heat and time, sterilizing at temperatures significantly lower than previously thought to be effective.
  • Previous dry heat sterilization methods have required temperatures of at least 16O o C to 18O o C. Heating times at these temperatures were from 2 hours at 16O o C to 30 minutes at 18O o C.
  • the 2-cyanoacrylate adhesive compositions can be sterilized at temperatures from about 7O o C to about 14O o C.
  • the time required to effect sterilization will vary depending on the temperature selected to accomplish the sterilization.
  • 14O o C sterilization requires approximately 30 minutes.
  • 7O o C sterilization requires about 600 minutes.
  • Required heating times for intermediate temperatures are reported in Tables 2 and 3.
  • Ultimately sterilization times for any composition can be readily determined by one skilled in the art by standard test methods without undue experimentation. Typical sterilization times are listed in Table 1.
  • sterilization of cyanoacrylate compositions can be assayed for the effectiveness of a given temperature and sterilization time.
  • spores can be introduced into the cyanocrylate adhesive compositions prior to sterilization using commercially available biological indicators or spore test strips.
  • bacterial spores on a stainless steel disc bacterial spores on a steel wire
  • bacterial spores on steel coupons bacterial spores on borosilicate paper
  • bacterial spores on woven cotton threads bacterial spores on woven cotton threads.
  • species of spores which may be chosen for use in the commercially available biological indicators are Bacillus subtillis and Geobacillus Stearothermophillus.
  • Commercially available biological indicators may be obtained from any commercial supplier, such as Raven Labs. Some inoculated glass vials and tubes samples were kept at room temperature without sterilization as positive controls, while the rest of the samples were sterilized at temperatures ranging from 70 to 14O o C with different time exposures. Samples were sent to a microbiology laboratory for determination of the presence or absence of growth after the sterilization procedure was completed to assay the effectiveness of the process conditions.
  • microorganisms which may be killed by the sterilization process but which show significant resistance to this process.
  • microorganism refers to bacteria, fungi, yeast, protozoa algae, viruses and protozoa.
  • Bacterial spores are very resistant to heat and chemicals; more so than vegetative bacterial cells, therefore the spores are often used to monitor sterilization procedures.
  • a preferred organism for monitoring dry heat sterilization is Bacillus subtillis.
  • the spores represent a resting stage in the life cycle of the Bacillus genus.
  • the resting spore contains a large number of active enzymes which allow the transformation from dormant cell to vegetative cell.
  • the germination process, or the return to the vegetative state has been described as a time-ordered sequence involving activation, triggering, initiation and outgrowth.
  • Activation is reversible and involves an increase in the rate and extent of germination.
  • Triggering is irreversible and is the result of spore contact with the germinant. Initiation involves the loss of heat resistance, release of dipicolinic acid and calcium, loss of refractility and' absorbance Outgrowth results in formation of the vegetative cell.
  • a cyanoacrylate composition test sample comprising at least one sterility test strip, or lyophilized spores is utilized. While reference is made to "spores" as a test microorganism it should be understood that microorganisms other than spore formers may be used in conjunction with the present invention.
  • the spore strips utilized with the present invention are preferably constructed of a material which is inert to the microorganisms and inert to cyanoacrylate monomer. A variety of commercial spore strips are readily available and can be utilized with the present invention. The spore strips can contain more than one type of microorganism.
  • the compositions including the biological indicators are transferred into containers filled with an aqueous aldose solution, shaken, and transferred into a quantity of nutrient medium in an aseptic container. Transferring the samples to a aldose solution serves to emulsify the cyanoacrylate monomer without causing it to polymerize as it would upon exposure to water alone.
  • Aldoses which act to emulsify the cyanoacrylate include without limitation, dextrose, lactose, arabinose, mannose, galactose, rhamnose, fructose, sucrose and glucose. In one embodiment of the invention, the aldose is dextrose.
  • the concentration of the aldose solution may be from about 2% to about 50% on a weight/weight basis. A preferred range for the concentration of the aldose solution is from about 3% to about 15%. A more preferred aldose concentration is from about 5% to about 10% weight/weight.
  • the nutrient medium supports the germination of spores and growth of any viable microorganisms.
  • the nutrient medium contains a protein substrate for the proteases liberated during spore germination and during subsequent microbial growth.
  • the nutrient medium preferably comprises an aqueous solution or suspension of nutrient components (including the protein substrate) needed in order to promote the growth of viable microorganisms that may exist after the sterilization process.
  • a suitable culture medium is a protein containing microbiological broth such as tryptic soy broth (TSB) and/or TSB with specific protein additives, such as, for example casein.
  • TSB tryptic soy broth
  • TSB specific protein additives
  • Formulations for culture media are well-known to those in the art.
  • the mixture of microorganisms, cyanoacrylate, aldose and nutrient medium are then sealed within a containing means.
  • the samples are then incubated for a predetermined period of time at from about 28 o C to about 37 o C. Any microorganisms not killed during the sterilization process begin to germinate and grow during the incubation period. In a preferred embodiment the microorganisms are incubated for at least about seven days. Thereafter the sample is examined to detect the presence of growth by different methods, such as visual examination of the samples followed by microscope Gram stain examination, addition of an enzymatic indicator such as Tetrazolium salts followed by UV spectrophotometry analysis, or direct UV spectrophotometric analysis of incubated samples.
  • a gram stain smear is prepared to look for gram positive rods which would confirm growth.
  • growth can be determined by the addition of enzymatic biological indicator such as Tetrazolium salts, wherein bacterial activity is determined by development of color which may be measured quantitatively with a Ultraviolet spectrophotometer at 257 nm.
  • a sample without enzymatic indicator is analyzed under a spectrophotometer at a wavelength of 480 nm to determine growth.
  • the method of the invention can be applied in principle to any 2-cyanoacrylate ester monomer.
  • the 2-cyanoacrylate is preferably an aliphatic cyanoacrylate ester and preferably an alkyl, cycloalkyl, alkenyl, alkoxyalkyl, fluroroalkyl, fluorocyclic alkyl or fluoroalkoxy 2- cyanoacrylate ester.
  • the alkyl group may contain from 2 to 12 carbon atoms, and is preferably a C 2 to C 8 alkyl ester, and is most preferably a C 4 to C 8 alkyl ester.
  • Suitable 2-cyanoacrylate esters include without limitation, the ethyl, n-propyl, iso-propyl, n-butyl, pentyl, hexyl, cyclohexyl, heptyl, n-octyl, 2-ethylhexyl, 2-methoxyethyl and 2-ethoxyethyl esters. Any of these 2-cyanoacrylate monomers may be used alone, or they may be used in mixtures.
  • the 2-cyanoacrylate monomers of the invention can be prepared by any of the methods known in the art.
  • U.S. Patent Nos/ 2,721,858, 3,254,1 1 1 and 4,364,876 each of which is hereby incorporated in its entirety by reference, disclose methods for preparing 2-cyanoacrylates.
  • cyanoacrylates for the instant invention were prepared by reacting cyanoacetate with formaldehyde in the presence of heat and a basic condensation catalyst to give a low molecular weight polymer. A depolymerization step followed under heat and vacuum in the presence of acidic and anionic inhibitors, yielding a crude monomer that could be distilled under vacuum and in the presence of radical and acidic inhibitors. The distilled 2-cyanoacrylate monomers are then formulated with radical and acidic inhibitors depending upon their application and to provide the necessary stability.
  • the 2-cyanoacrylate compositions of the invention may in some embodiments contain a thickening agent to increase the viscosity of the composition.
  • This thickening agent may be a polymer.
  • the thickening agent may be selected from the group consisting of without limitation, poly aIkyl-2-cyanoacrylates, poly cycloalkyl-2-cyanoacrylates, poly fluoroalkyl-2- cyanoacrylates, poly fluorocycloalkyl-2-cyanoacrylates, poly alkoxyalkyl-2-cyanoacrylates, poly aIkoxycycIoaIkyl-2-cyanoacrylates, poly fluoroalkoxyalkyl-2-cyanoacrylates, polyalkoxycyclofluoroalkyl-2-cyanoacrylates, poly vinylacetate, poly lactic acid and poly gylcolic acid.
  • the polymer is often chosen to be a polymer of the monomer or one of the monomers which comprise the 2- cyanoacrylate composition.
  • the polymer is soluble in the monomer composition at ambient temperature.
  • Preferred polymers include polymers of octyl 2-cyanoacrylate, vinyl acetate lactic acid, or glycolic acid.
  • the preferred weight average molecular weight of the polymers is from about 300,000 to about 2,000,000. More preferably, the polymer molecular weight is from about 500,000 to about 1,600,000.
  • Cyanoacrylate polymers of the invention can be prepared by slow addition of the monomer to a mixer containing 0.1% Bicarbonate deionized water. Water is then decanted away, and the polymer is rinsed several times with deionized water and decanted again. Following steps include neutralizing the polymer with 0.1N HCL, rinsing with deionized water, drying on a vacuum heated oven at temperature of less than 80 o C and grinding polymer to fine particles.
  • the amount of thickening agent that is added to the monomer composition is dependent upon the molecular weight of the polymer, and the desired viscosity for the adhesive composition.
  • the thickening agent typically is added at from about 1 % to about 25% by weight of the composition. Preferably it is added at from about 1 % to about 10%. More preferably it is added at from about 1% to about 5%.
  • a typical viscosity of the composition is from about 25 to about 3000 centipoise, as measured by a Brookfield viscometer at 25 o C. Preferably, the viscosity is between from about 50 to 600 centipoise at 25 o C.
  • the specific amount of a given thickening agent to be added can be determined by one of ordinary skill in the art without undue experimentation.
  • the 2-Cyanoacrylate compositions may contain one or more acidic inhibitors in the range from 1 to 1,000 ppm.
  • acidic inhibitors include without limitation: sulfur dioxide, nitrogen oxide, boron -oxide, phosphoric acid, ortho, meta, or para-phosphoric acid, acetic acid, benzoic acid, cyanoacetic acid, tri-fluoroacetic acid, tribromoacetic acid, trichloroacetic acid, boron trifluoride, hydrogen fluoride, perchloric acid, hydrochloric acid, hydrobromic acid, sulfonic acid, fluorosulfonic acid, chlorosulfonic acid, sulfuric acid, and toluenesulfonic acid.
  • the 2-Cyanoacrylate compositions may contain one or more free radical polymerization inhibitors in the range from 0 to 10,000 ppm.
  • radical inhibitors include without limitation, catechol, hydroquinone, hydroquinone monomethyl ether and hindered phenols such as butylated hydroxyanisol; bButylated hydroxytoluene (2,6-di-tert-butyl butylphenol and 4- methoxyphenol); 4-ethoxyphenol; 3 methoxyphenol; 2-tert-butyl-4methoxyphenol; 2,2methylene-bis-(4-methyl-6-tert-butylphenol).
  • the 2-Cyanoacrylate compositions may contain single or mixtures of plasticizers such as tributyl acetyl citrate; dimethyl sebacate; diethyl sebacate; try-ethyl phosphate; tri-(2- ethylhexyl)phosphate; tri-cresyl phosphate; glyceryl triacetate; glyceryl tributyrate; dioctyl adipate; isopropyl myristate; butyl stearate; trioctyl trimellitate and dioctyl glutarate.
  • the plasticizers may be added to the compositions in proportions of less than 50% w/w of the formulation.
  • the 2-Cyanoacrylate compositions may contain small amounts of dyes like the derivatives of anthracene and other complex structures. Some of these dyes include without limitation, 1 -hydroxy-4-[4-methylphenylamino] -9, 10 anthracenedione (D&C violet No.
  • the sterilized cyanoacrylate adhesive compositions of the invention may be packaged in a container made of any suitable material. Suitable materials must be heat stable and resistant up to the sterilization temperature, must provide an adequate barrier to atmospheric moisture and be compatible with the cyanoacrylate monomer or monomers. Materials meeting these requirements include metals and borosilicate type I glass. Suitable metals can include without limitation aluminum, tin and stainless steel. Metals can have different forms like pouches and tubes. Glass can be used as vials, breakable tubes or any other shape, and contained inside tubes made out of the same material, or combinations or materials including plastics. Particularly preferred materials are aluminum and type I glass.
  • Preferred aluminum tubes comprise a nozzle which is hermetically sealed by a pierceable membrane of aluminum and are filled at their end remote from the nozzle prior to closure of the open end by tight crimping.
  • the glass vials used in this invention are made out of borosilicate type I glass and sealed with a threaded phenolic cap with a silicone/teflon septa or sealed with an aluminum crimp cap and silicon/teflon septa.
  • a substantially hermetically sealed aluminum container e.g., an aluminum tube, containing a sterile 2- cyanoacrylate composition or type 1 glass vials hermetically sealed with a phenolic threaded and silicone/teflon septa.
  • the method was tested by first performing the USP bacteriostasis and fungistasis test on glass vials and aluminum tubes.
  • the sterility test was performed by obtaining spores of Bacillus subtilis var niger suspended in irrigation water at a concentration of 2.3X 10 +8 ml. Aliquots of 0.48 ml of these spores were placed in glass serum bottles, lyophilized and them reconstituted with 50 ml of n-Butyl or 2-Octylcyanoacrylate compositions to obtain a volume of 50 ml of inoculated spores solution with a concentration of 2 x 10 +6 ml.
  • Cyanoacrylate spores solution were used to fill the tubes and vials for the sterilization trials at different temperatures and time and for the non sterilized (standard biological indicators) control vials and tubes.
  • Each tube and vial was filled with a volume of 0.5 to 0.6 ml of a cyanoacrylate composition that rendered a spore concentration of 2X 10 +6 ml.
  • Non sterilized BI's and sterilized spores inoculated samples at different temperatures and time were transferred to a 5% Dextrose USP solution, shaken and transferred to Soy Casein Digested Broth (SCDB) and incubated at 35-37 o C for at least seven days.
  • SCDB Soy Casein Digested Broth
  • a vial of lyophilized spores with no cyanoacrylate was tested for population verification.
  • the vial was transferred to Sterile Purified Water and vortexed for 10 minutes.
  • Serial dilutions of 10 +4 , 10 +5 , 10 +6 were plated in duplicate using Soy Bean Casein Digest Broth (SCDA) and incubated for 48 hour at 35-37 o C.
  • SCDA Soy Bean Casein Digest Broth
  • the 10 +6 dilution yielded duplicate plates in the countable range.
  • the final calculations showed there were 6.1X 10 +6 CFU/mI, or 3.1 X 10 +7 CFU/vial.
  • Polymer preparation (polymer method for samples containing polymer)
  • 2-OCA polymer was made by adding drop by drop 30 grams of 2-OCA monomer to a blender containing 1000ml of 0, 1% Sodium bicarbonate deionized water while swirling.
  • Bicarbonate water with the polymer was vacuum filtered on a Kitasato with a Fisherbrand #Q5 quantitative filter paper, rinsed five times with 500ml aliquots of deionize water, decanted and polymer neutralized with 500 ml of 0.1 N Hydrochloric acid.
  • the neutralized polymer was rinsed with three aliquots of 500 ml, decanted, dried in a vacuum oven at 80 o C and fine grinded with mixer after drying.
  • the sample of 2-OCA containing polymer was made by mixing 2-Octyl cyanoacrylate
  • Tubes were sealed by crimping with a Kentex automatic tubes filler and sealer.
  • the glass vials were filled with an Eppendorf automatic pipette and sealed with threaded phenol caps and silicone/teflon septa.
  • Some inoculated glass and tubes samples were not sterilized and were used as positive Standard Biological Indicators to indicate livable spores.
  • the rest of the inoculated and sealed tubes and vials were exposed to the experimental temperatures and time stipulated in the sterilization testing protocol conditions.
  • Table #2 above shows minimum sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Bacillus subtillis spores inoculated 2-OCA containing 3.5% 2-OCA polymer ( 567 cP), 100 ppm SO 2 and 1000 ppm BHA.
  • Table #3 above shows minimum sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Bacillus subtillis spores inoculated 2-OCA containing 3.5% 2-OCA polymer ( 567 cP), 100 ppm SO 2 and 1000 ppm BHA.
  • n-Butyl cyanoacrylate with a viscosity of 2.8 cP (measured with Brookfield DV-II at 25 0 C) ⁇ nia ⁇ ntog 100 ppm of SO 2 and 1000 ppm of Butylated Hydroxyanisole (BHA) was prepared for this example. Then, the composition was inoculated with Biological Indicator standards (BI) such as borosilicate spore discs, cotton threads and spore wires with a spores concentration of IXlO 6 Geobaciilus stearothermophilus.
  • BI Biological Indicator standards
  • the spores inoculated composition was filled in glass type I glass threaded vials with an Eppendorf automatic pipette and sealed with threaded phenol caps and silicone/teflon septa. Some inoculated glass were not sterilized and were used as positive Standard Biological Indicators to indicate livable spores. The rest of the inoculated sealed vials were exposed to the experimental temperatures and time stipulated in the sterilization testing protocol conditions. Table #4shows example results.
  • Table #4 above shows sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Geohacilius stearothermophilus spores inoculated n-BCA containing, 100 ppm SO 2 and 1000 ppm BHA.
  • SAMPLE II B A sample, oAin-Baty-I ⁇ &mx ⁇ & ⁇ l&te (n-BCA) with a viscosity of 2.8 cP (measured with Brookfield DV-II at 25°C) containing 100 ppm of SO 2 and 1000 ppm of Butylated Hydroxyanisole (BHA) was prepared for this example. Then, the composition was inoculated with Biological Indicator standards (BI) cotton threads with a spores concentration of IXlO 6 Bacillus subtillis.
  • BI Biological Indicator standards
  • the spores inoculated composition was filled in glass type I glass threaded vials with an Eppendorf automatic pipette and sealed with threaded phenol caps and silicone/teflon septa. Some inoculated glass were not sterilized and were used as positive Standard Biological Indicators to indicate livable spores. The rest of the inoculated sealed vials were exposed to the experimental temperatures and time stipulated in the sterilization testing protocol conditions.
  • Table #5 above shows sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Bacillus subtillis spores inoculated n-BCA containing, 100 ppm SO 2 and 1000 ppm BHA.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Discosed are a process for sterilization of cyanoacrylate adhesive compositions, the compositions, comprising 2-cyanoacrylate ester monomers, so produced and a method for assaying the effectiveness of the sterilization process. The process comprises heating the adhesive composition to from about 70°C to about 140°C for an effective amount of time. The effectiveness of the process can be assayed by disposing bacterial spores in the cyanoacrylate monomer, exposing the composition to a dry heat sterilization process, transferring the cyanoacrylate composition to a sterile aldose solution, transferring and exposing the sample to a nutrient medium which supports germination and growth of viable spores, incubating the samples, and determining the presence or absence of growth.

Description

TITLE: Process for Sterilization of and Cyanoacrylate Adhesive Compositions and Devices
BACKGROUND OF THE INVENTION
Field of the Invention
The invention relates to compositions of cyanoacrylate monomer and polymer adhesive compositions, a process for sterilizing them for application in the medical and veterinary fields, and a method of assaying the sterilization of cyanoacrylate compositions.
Background
It is known to use 2-cyanoacrylate esters as adhesives for bonding tissue in medical or surgical procedures performed upon the human or animal body. 2-cyanoacrylate esters polymerize rapidly, and often instantaneously, upon contact with tissue or body fluid. In these applications, the adhesive composition can be used to close wounds, as well as for covering and protecting surface injuries such as lacerations, abrasions, burns, sores and other open surface wounds. To be used in medical and veterinary fields, 2-cyanoacrylates must be sterilized. This is generally done in sealed containers to provide sterility, and from a practical perspective, to protect the compositions from moisture and premature polymerization. Previous sterilization methods involved either the use of ionizing radiation, including e-beam and gamma ray irradiation, dry heat at elevated temperatures (16OºC), or chemical sterilization such as with ethylene oxide.
When an adhesive composition is applied to a surface to be closed or protected, it is usually in its monomeric form, and the resultant polymerization produces the desired adhesive bond. However, at ordinary temperatures, the monomeric form of the adhesive has a low viscosity which results in the adhesive spreading into undesired areas. Therefore, it is desirable to increase the viscosity of the composition to prevent this unwanted flow. In order to achieve an increased viscosity, thickening agents can be added to the monomeric composition.
The previous methods of sterilization are undesirable in that the high temperatures required for the previous dry heat sterilization processes or irradiation could cause premature polymerization of the monomers. In addition, many polymers that could be used as thickeners underwent degradation resulting in loss of viscosity when exposed to typical dry heat conditions of 16OºC. This significantly limits the formulators ability to formulate adhesive compositions which have the desirable stability and flow characteristics, and which can be sterilized.
BRIEF SUMMARY OF THE INVENTION
The present invention is directed to a method of sterilizing 2-cyanoacrylate compositions, including heating the composition in a device at a temperature of from about 7OºC to about 14OºC for an effective amount of time. In another aspect, the invention includes sterilized 2-cyanoacrylate ester compositions for use in medical applications or surgery, the compositions being disposed in sealed aluminum containers and being sterilized at a temperature of between about 7OºC and about 14OºC. The compositions can be disposed in sealed aluminum, tin, stainless steel tubes or pouches or glass containers. In yet another aspect, the invention is directed to a method for assaying the sterilization of cyanoacrylate compositions.
BRIEF SUMMARY OF THE INVENTION
As embodied and described herein, the present invention provides a novel method of sterilizing 2-Cyanoacrylate ester compositions using a dry heat means, and the resulting novel compositions. The combination of monomeric 2-Cyanoacrylate, heat and time have a lethal effect on microbials, rendering sterilized compositions when the appropriate sterilization condition is achieved and when the method is applied to 2-Cyanoacrylates in sealed containers.
As used herein, the following terms have the following meanings: The term "cyanoacrylate adhesive composition" or "cyanoacrylate adhesive compositions" refers to polymerizable formulations comprising polymerizable cyanoacrylate ester monomers.
The term aldose is intended to refer to both common disacharides and monosacharides.
In the method of the invention, 2-cyanoacrylate adhesive compositions are sterilized through an unexpected and heretofore unknown combination of heat and time, sterilizing at temperatures significantly lower than previously thought to be effective. Previous dry heat sterilization methods have required temperatures of at least 16OºC to 18OºC. Heating times at these temperatures were from 2 hours at 16OºC to 30 minutes at 18OºC. Under the present invention, the 2-cyanoacrylate adhesive compositions can be sterilized at temperatures from about 7OºC to about 14OºC. As would be expected, the time required to effect sterilization will vary depending on the temperature selected to accomplish the sterilization. At 14OºC, sterilization requires approximately 30 minutes. At 7OºC, sterilization requires about 600 minutes. Required heating times for intermediate temperatures are reported in Tables 2 and 3. Ultimately sterilization times for any composition can be readily determined by one skilled in the art by standard test methods without undue experimentation. Typical sterilization times are listed in Table 1.
Table #1 sterilization heating times
7OºC 600 minutes
8OºC 480 minutes
9OºC 300 minutes
100ºC 120 minutes
HOºC 90 minutes
120ºC 60 minutes 13 0ºC 60 minutes 14OºC 30 minutes
According to the assay method of the invention, sterilization of cyanoacrylate compositions can be assayed for the effectiveness of a given temperature and sterilization time. Samples containing formulated n-Butyl cyanoacrylate and 2-Octyl cyanoacrylate in sealed borosilicate glass and aluminum tubes, were inoculated with Bacillus subtillis lyophilized spores at a concentration of IX 10+6 per ml of formulation. In other embodiments, spores can be introduced into the cyanocrylate adhesive compositions prior to sterilization using commercially available biological indicators or spore test strips. Among the commercially available biological indicators which may be used are: bacterial spores on a stainless steel disc, bacterial spores on a steel wire, bacterial spores on steel coupons, bacterial spores on borosilicate paper and bacterial spores on woven cotton threads. Among the species of spores which may be chosen for use in the commercially available biological indicators are Bacillus subtillis and Geobacillus Stearothermophillus. Commercially available biological indicators may be obtained from any commercial supplier, such as Raven Labs. Some inoculated glass vials and tubes samples were kept at room temperature without sterilization as positive controls, while the rest of the samples were sterilized at temperatures ranging from 70 to 14OºC with different time exposures. Samples were sent to a microbiology laboratory for determination of the presence or absence of growth after the sterilization procedure was completed to assay the effectiveness of the process conditions.
In accordance with the present invention it is preferred to utilize microorganisms which may be killed by the sterilization process but which show significant resistance to this process. The term microorganism refers to bacteria, fungi, yeast, protozoa algae, viruses and protozoa. Bacterial spores are very resistant to heat and chemicals; more so than vegetative bacterial cells, therefore the spores are often used to monitor sterilization procedures. A preferred organism for monitoring dry heat sterilization is Bacillus subtillis.
The spores represent a resting stage in the life cycle of the Bacillus genus. The resting spore contains a large number of active enzymes which allow the transformation from dormant cell to vegetative cell. The germination process, or the return to the vegetative state, has been described as a time-ordered sequence involving activation, triggering, initiation and outgrowth. Activation is reversible and involves an increase in the rate and extent of germination. Triggering is irreversible and is the result of spore contact with the germinant. Initiation involves the loss of heat resistance, release of dipicolinic acid and calcium, loss of refractility and' absorbance Outgrowth results in formation of the vegetative cell.
In accordance with the present invention a cyanoacrylate composition test sample comprising at least one sterility test strip, or lyophilized spores is utilized. While reference is made to "spores" as a test microorganism it should be understood that microorganisms other than spore formers may be used in conjunction with the present invention. The spore strips utilized with the present invention are preferably constructed of a material which is inert to the microorganisms and inert to cyanoacrylate monomer. A variety of commercial spore strips are readily available and can be utilized with the present invention. The spore strips can contain more than one type of microorganism.
To assay the sterilized samples and controls, the compositions including the biological indicators are transferred into containers filled with an aqueous aldose solution, shaken, and transferred into a quantity of nutrient medium in an aseptic container. Transferring the samples to a aldose solution serves to emulsify the cyanoacrylate monomer without causing it to polymerize as it would upon exposure to water alone. Aldoses which act to emulsify the cyanoacrylate include without limitation, dextrose, lactose, arabinose, mannose, galactose, rhamnose, fructose, sucrose and glucose. In one embodiment of the invention, the aldose is dextrose. The concentration of the aldose solution may be from about 2% to about 50% on a weight/weight basis. A preferred range for the concentration of the aldose solution is from about 3% to about 15%. A more preferred aldose concentration is from about 5% to about 10% weight/weight. The nutrient medium supports the germination of spores and growth of any viable microorganisms. The nutrient medium contains a protein substrate for the proteases liberated during spore germination and during subsequent microbial growth. The nutrient medium preferably comprises an aqueous solution or suspension of nutrient components (including the protein substrate) needed in order to promote the growth of viable microorganisms that may exist after the sterilization process. One example of a suitable culture medium is a protein containing microbiological broth such as tryptic soy broth (TSB) and/or TSB with specific protein additives, such as, for example casein. Formulations for culture media are well-known to those in the art.
The mixture of microorganisms, cyanoacrylate, aldose and nutrient medium are then sealed within a containing means. The samples are then incubated for a predetermined period of time at from about 28ºC to about 37ºC. Any microorganisms not killed during the sterilization process begin to germinate and grow during the incubation period. In a preferred embodiment the microorganisms are incubated for at least about seven days. Thereafter the sample is examined to detect the presence of growth by different methods, such as visual examination of the samples followed by microscope Gram stain examination, addition of an enzymatic indicator such as Tetrazolium salts followed by UV spectrophotometry analysis, or direct UV spectrophotometric analysis of incubated samples. In one embodiment, after visual examination a gram stain smear is prepared to look for gram positive rods which would confirm growth. In another embodiment, growth can be determined by the addition of enzymatic biological indicator such as Tetrazolium salts, wherein bacterial activity is determined by development of color which may be measured quantitatively with a Ultraviolet spectrophotometer at 257 nm. In yet another embodiment, a sample without enzymatic indicator, is analyzed under a spectrophotometer at a wavelength of 480 nm to determine growth.
The method of the invention can be applied in principle to any 2-cyanoacrylate ester monomer. The 2-cyanoacrylate is preferably an aliphatic cyanoacrylate ester and preferably an alkyl, cycloalkyl, alkenyl, alkoxyalkyl, fluroroalkyl, fluorocyclic alkyl or fluoroalkoxy 2- cyanoacrylate ester. The alkyl group may contain from 2 to 12 carbon atoms, and is preferably a C2 to C8 alkyl ester, and is most preferably a C4 to C8 alkyl ester. Suitable 2-cyanoacrylate esters include without limitation, the ethyl, n-propyl, iso-propyl, n-butyl, pentyl, hexyl, cyclohexyl, heptyl, n-octyl, 2-ethylhexyl, 2-methoxyethyl and 2-ethoxyethyl esters. Any of these 2-cyanoacrylate monomers may be used alone, or they may be used in mixtures.
The 2-cyanoacrylate monomers of the invention can be prepared by any of the methods known in the art. U.S. Patent Nos/ 2,721,858, 3,254,1 1 1 and 4,364,876 each of which is hereby incorporated in its entirety by reference, disclose methods for preparing 2-cyanoacrylates. For example, cyanoacrylates for the instant invention were prepared by reacting cyanoacetate with formaldehyde in the presence of heat and a basic condensation catalyst to give a low molecular weight polymer. A depolymerization step followed under heat and vacuum in the presence of acidic and anionic inhibitors, yielding a crude monomer that could be distilled under vacuum and in the presence of radical and acidic inhibitors. The distilled 2-cyanoacrylate monomers are then formulated with radical and acidic inhibitors depending upon their application and to provide the necessary stability.
The 2-cyanoacrylate compositions of the invention may in some embodiments contain a thickening agent to increase the viscosity of the composition. This thickening agent may be a polymer. The thickening agent may be selected from the group consisting of without limitation, poly aIkyl-2-cyanoacrylates, poly cycloalkyl-2-cyanoacrylates, poly fluoroalkyl-2- cyanoacrylates, poly fluorocycloalkyl-2-cyanoacrylates, poly alkoxyalkyl-2-cyanoacrylates, poly aIkoxycycIoaIkyl-2-cyanoacrylates, poly fluoroalkoxyalkyl-2-cyanoacrylates, polyalkoxycyclofluoroalkyl-2-cyanoacrylates, poly vinylacetate, poly lactic acid and poly gylcolic acid. In order to obtain optimum solubility of the polymer in the monomer, the polymer is often chosen to be a polymer of the monomer or one of the monomers which comprise the 2- cyanoacrylate composition. Preferably, the polymer is soluble in the monomer composition at ambient temperature. Preferred polymers include polymers of octyl 2-cyanoacrylate, vinyl acetate lactic acid, or glycolic acid. The preferred weight average molecular weight of the polymers is from about 300,000 to about 2,000,000. More preferably, the polymer molecular weight is from about 500,000 to about 1,600,000.
Cyanoacrylate polymers of the invention can be prepared by slow addition of the monomer to a mixer containing 0.1% Bicarbonate deionized water. Water is then decanted away, and the polymer is rinsed several times with deionized water and decanted again. Following steps include neutralizing the polymer with 0.1N HCL, rinsing with deionized water, drying on a vacuum heated oven at temperature of less than 80ºC and grinding polymer to fine particles.
The amount of thickening agent that is added to the monomer composition is dependent upon the molecular weight of the polymer, and the desired viscosity for the adhesive composition. The thickening agent typically is added at from about 1 % to about 25% by weight of the composition. Preferably it is added at from about 1 % to about 10%. More preferably it is added at from about 1% to about 5%. A typical viscosity of the composition is from about 25 to about 3000 centipoise, as measured by a Brookfield viscometer at 25ºC. Preferably, the viscosity is between from about 50 to 600 centipoise at 25ºC. The specific amount of a given thickening agent to be added can be determined by one of ordinary skill in the art without undue experimentation.
The 2-Cyanoacrylate compositions may contain one or more acidic inhibitors in the range from 1 to 1,000 ppm. Such acidic inhibitors include without limitation: sulfur dioxide, nitrogen oxide, boron -oxide, phosphoric acid, ortho, meta, or para-phosphoric acid, acetic acid, benzoic acid, cyanoacetic acid, tri-fluoroacetic acid, tribromoacetic acid, trichloroacetic acid, boron trifluoride, hydrogen fluoride, perchloric acid, hydrochloric acid, hydrobromic acid, sulfonic acid, fluorosulfonic acid, chlorosulfonic acid, sulfuric acid, and toluenesulfonic acid.
The 2-Cyanoacrylate compositions may contain one or more free radical polymerization inhibitors in the range from 0 to 10,000 ppm. Examples such radical inhibitors include without limitation, catechol, hydroquinone, hydroquinone monomethyl ether and hindered phenols such as butylated hydroxyanisol; bButylated hydroxytoluene (2,6-di-tert-butyl butylphenol and 4- methoxyphenol); 4-ethoxyphenol; 3 methoxyphenol; 2-tert-butyl-4methoxyphenol; 2,2methylene-bis-(4-methyl-6-tert-butylphenol).
The 2-Cyanoacrylate compositions may contain single or mixtures of plasticizers such as tributyl acetyl citrate; dimethyl sebacate; diethyl sebacate; try-ethyl phosphate; tri-(2- ethylhexyl)phosphate; tri-cresyl phosphate; glyceryl triacetate; glyceryl tributyrate; dioctyl adipate; isopropyl myristate; butyl stearate; trioctyl trimellitate and dioctyl glutarate. The plasticizers may be added to the compositions in proportions of less than 50% w/w of the formulation.
The 2-Cyanoacrylate compositions may contain small amounts of dyes like the derivatives of anthracene and other complex structures.. Some of these dyes include without limitation, 1 -hydroxy-4-[4-methylphenylamino] -9, 10 anthracenedione (D&C violet No. 2); disodium salt of 6-hydroxy-5-[(4-sulfophenyl)axo]-2-naphthalene-sulfonic acid (FD&C Yellow No.6,); 9-(o- carboxyphenyl)-6-hydroxy-2,4,5,7-tetraiodo-3H-xanthen-3-one,disodium salt, monohydrate (FD&C Red No.3); 2-(l,3dihydro-3-oxo-5-sulfo-2H-indole-2-ylidine)-2,3- dihydro-3-oxo-l H-indole-5-sulfonic acid disodium salt (FD&C Blue No.2); and [phthalocyaninato (2)] copper, add in proportions of less than 50000ppm.
The sterilized cyanoacrylate adhesive compositions of the invention may be packaged in a container made of any suitable material. Suitable materials must be heat stable and resistant up to the sterilization temperature, must provide an adequate barrier to atmospheric moisture and be compatible with the cyanoacrylate monomer or monomers. Materials meeting these requirements include metals and borosilicate type I glass. Suitable metals can include without limitation aluminum, tin and stainless steel. Metals can have different forms like pouches and tubes. Glass can be used as vials, breakable tubes or any other shape, and contained inside tubes made out of the same material, or combinations or materials including plastics. Particularly preferred materials are aluminum and type I glass. Preferred aluminum tubes comprise a nozzle which is hermetically sealed by a pierceable membrane of aluminum and are filled at their end remote from the nozzle prior to closure of the open end by tight crimping. The glass vials used in this invention, are made out of borosilicate type I glass and sealed with a threaded phenolic cap with a silicone/teflon septa or sealed with an aluminum crimp cap and silicon/teflon septa. In the result, therefore, preferred embodiments of the invention reside in a substantially hermetically sealed aluminum container, e.g., an aluminum tube, containing a sterile 2- cyanoacrylate composition or type 1 glass vials hermetically sealed with a phenolic threaded and silicone/teflon septa.
EXAMPLES
Example I
Sample testing: (Sterility test method for all samples)
The method was tested by first performing the USP bacteriostasis and fungistasis test on glass vials and aluminum tubes. The sterility test was performed by obtaining spores of Bacillus subtilis var niger suspended in irrigation water at a concentration of 2.3X 10+8 ml. Aliquots of 0.48 ml of these spores were placed in glass serum bottles, lyophilized and them reconstituted with 50 ml of n-Butyl or 2-Octylcyanoacrylate compositions to obtain a volume of 50 ml of inoculated spores solution with a concentration of 2 x 10+6 ml. These Cyanoacrylate spores solution were used to fill the tubes and vials for the sterilization trials at different temperatures and time and for the non sterilized (standard biological indicators) control vials and tubes. Each tube and vial was filled with a volume of 0.5 to 0.6 ml of a cyanoacrylate composition that rendered a spore concentration of 2X 10+6 ml. Non sterilized BI's and sterilized spores inoculated samples at different temperatures and time, were transferred to a 5% Dextrose USP solution, shaken and transferred to Soy Casein Digested Broth (SCDB) and incubated at 35-37ºC for at least seven days. A vial of lyophilized spores with no cyanoacrylate was tested for population verification. The vial was transferred to Sterile Purified Water and vortexed for 10 minutes. Serial dilutions of 10+4, 10+5, 10+6 were plated in duplicate using Soy Bean Casein Digest Broth (SCDA) and incubated for 48 hour at 35-37 ºC. The 10+6 dilution yielded duplicate plates in the countable range. The final calculations showed there were 6.1X 10+6 CFU/mI, or 3.1 X 10+7 CFU/vial.
Polymer preparation: (polymer method for samples containing polymer)
2-OCA polymer was made by adding drop by drop 30 grams of 2-OCA monomer to a blender containing 1000ml of 0, 1% Sodium bicarbonate deionized water while swirling.
Bicarbonate water with the polymer was vacuum filtered on a Kitasato with a Fisherbrand #Q5 quantitative filter paper, rinsed five times with 500ml aliquots of deionize water, decanted and polymer neutralized with 500 ml of 0.1 N Hydrochloric acid. The neutralized polymer was rinsed with three aliquots of 500 ml, decanted, dried in a vacuum oven at 80ºC and fine grinded with mixer after drying.
Sample composition preparation:
The sample of 2-OCA containing polymer was made by mixing 2-Octyl cyanoacrylate
(stabilized with 100 ppm of SO2, 1000 ppm of Butylated Hydroxyanisole) with 3.5% of 2-OCA polymer. The polymer was dissolved in the formulated 2-OCA by heating and mixing in a round glass flask equipped with a paddle shaft and mixer at a temperature no higher than 800C and obtaining a viscosity of 567 Cp (measured with Brookfield DV-II at 25°C). Then, the composition was inoculated with lyophilized Bacillus suhtillis spores enough to produce a minimum concentration of IX 1O+6WhICh were filled in aluminum tubes and glass type I glass threaded vials. Tubes were sealed by crimping with a Kentex automatic tubes filler and sealer. The glass vials were filled with an Eppendorf automatic pipette and sealed with threaded phenol caps and silicone/teflon septa. Some inoculated glass and tubes samples were not sterilized and were used as positive Standard Biological Indicators to indicate livable spores. The rest of the inoculated and sealed tubes and vials were exposed to the experimental temperatures and time stipulated in the sterilization testing protocol conditions.
Tables #2-3 shows example results.
Table #2 2-OCA sterilization example packed in glass vials with pre-sterilization viscosity of 567 cP
Figure imgf000012_0001
l,4:o 1 45 SCJUhB 30-35 i 7 o I N/A
Table #2 above shows minimum sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Bacillus subtillis spores inoculated 2-OCA containing 3.5% 2-OCA polymer ( 567 cP), 100 ppm SO2 and 1000 ppm BHA.
Table #3 2-OCA sterilization example packed in aluminum tubes with pre-sterilization viscosity of 567 cP
Figure imgf000013_0001
Table #3 above shows minimum sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Bacillus subtillis spores inoculated 2-OCA containing 3.5% 2-OCA polymer ( 567 cP), 100 ppm SO2 and 1000 ppm BHA.
Example II
Sample composition preparation:
Sample IIA:
A sample of n-Butyl cyanoacrylate (n-BCA) with a viscosity of 2.8 cP (measured with Brookfield DV-II at 250C) Θυniaϊntog 100 ppm of SO2 and 1000 ppm of Butylated Hydroxyanisole (BHA) was prepared for this example. Then, the composition was inoculated with Biological Indicator standards (BI) such as borosilicate spore discs, cotton threads and spore wires with a spores concentration of IXlO6 Geobaciilus stearothermophilus. The spores inoculated composition was filled in glass type I glass threaded vials with an Eppendorf automatic pipette and sealed with threaded phenol caps and silicone/teflon septa. Some inoculated glass were not sterilized and were used as positive Standard Biological Indicators to indicate livable spores. The rest of the inoculated sealed vials were exposed to the experimental temperatures and time stipulated in the sterilization testing protocol conditions. Table #4shows example results.
Table #4 n-BCA monomer sterilization example in glass vials with pre-sterilization viscosity of 2.8 cP
Figure imgf000014_0001
Table #4 above shows sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Geohacilius stearothermophilus spores inoculated n-BCA containing, 100 ppm SO2 and 1000 ppm BHA.
SAMPLE II B: A sample, oAin-Baty-I ς&mxøβ&ψl&te (n-BCA) with a viscosity of 2.8 cP (measured with Brookfield DV-II at 25°C) containing 100 ppm of SO2 and 1000 ppm of Butylated Hydroxyanisole (BHA) was prepared for this example. Then, the composition was inoculated with Biological Indicator standards (BI) cotton threads with a spores concentration of IXlO6 Bacillus subtillis. The spores inoculated composition was filled in glass type I glass threaded vials with an Eppendorf automatic pipette and sealed with threaded phenol caps and silicone/teflon septa. Some inoculated glass were not sterilized and were used as positive Standard Biological Indicators to indicate livable spores. The rest of the inoculated sealed vials were exposed to the experimental temperatures and time stipulated in the sterilization testing protocol conditions.
Tables #5shows example results.
Table #5 n-BCA monomer sterilization example in glass vials with pre-sterilization viscosity of 2.8 cP
Sterilization Sterilization Type of Incubation Number i Number of Number Viscosity
100 0C time media temperature samples | days of ! 250C minutes 400 ml 0C tested incubated positives sterile
Cotton 240 SCDB 55-60 1 2 O .8 threads
Positive NO SCDB 55-60 2.8
Control cotton threads
Table #5 above shows sterilization temperatures, incubation temperature, incubation time and the results obtained for samples of Bacillus subtillis spores inoculated n-BCA containing, 100 ppm SO2 and 1000 ppm BHA.

Claims

1. A method of sterilization of 2-cyanoacrylate adhesive compositions, comprising; heating said composition in a device at a temperature of from about 7O0C to about 14O0C for a period of time sufficient to sterilize the composition.
2. A method according to claim 1 wherein said sterilization temperature is from about 7O0C to about 1 1O0C.
3. A method according to claim 1 wherein said sterilization temperature is from about 7O0C to about 1000C.
4. A method as in any one of claims 1, 2 and 3 wherein said cyanoacrylate composition comprises one or more 2-cyanoacrylate ester monomers wherein said cyanoacrylate ester monomer is an alkyl, cycloalkyl, fluoroalkyl, fluorocycloalkyl or fluoroalkoxy 2- cyanoacrylate monomer.
5. A method according to claim 3 wherein said cyanoacrylate composition further comprises at least one thickener selected from the group consisting of poly alkyl-2-cyanoacrylates, poly cycloalkyl-2-cyanoacrylates, poly fluoroalkyl-2-cyanoacrylates, poly fluorocycloalkyl-2- cyanoacrylates, poly alkoxyalkyl-2-cyanoacrylates, poly alkoxycycloalkyl-2- cyanoacrylates, poly fluoroalkoxyalkyl-2-cyanoacrylates, polyalkoxycyclofluoroalkyl-2- cyanoacrylates, poly lactic acid and poly gylcolic acid.
6. A method according to claim 5 wherein the at least one thickener is a poly alkyl-2- cyanoacrylate.
7. A method according to claim 6 wherein the alkyl group of the poly alkyl-2 -cyanoacrylate is selected from the group consisting of straight chain or branched chain C4 to Cs hydrocarbons.
8. A method according to claim 6 wherein said thickening polymer is poly octyl 2- cyanoacrylate.
9. A method according to claim 5 wherein the 2-cyanoacrylate composition further comprises a stabilizer.
10. A method according to claim 9 wherein said stabilizer is one or more of an anionic polymerization inhibitor or a free radical polymerization inhibitor.
1 1. A method according to claim 5 wherein said cyanoacrylate composition further comprises a plasticizer selected from the group consisting of tributyl acetyl citrate, dimethyl sebacate, diethyl sebacate, triethyl phosphate, tri-(2-ethylhexyl) phosphate, tricresyl phosphate, glycerol triacetate, glycerol tributyrate, dioctyl adipate, isopropyl myristate, butyl stearate, trioctyl trimellitate and dioctyl glutarate.
12. A method according to claim 1 1 wherein said plasticizer is up to 50% by weight of the cyanoacrylate composition.
13. A composition comprising a sterile 2-cyanoacrylate ester composition for use in medicine, or surgery, said composition disposed in a sealed aluminum container, said preparation sterilized by heating the composition to a temperature of from about 7O0C to about 14O0C for a period of time sufficient to sterilize said preparation.
14. A composition according to claim 13 wherein the sterilization temperature is from about 7O0C to about 1000C.
15. A composition as in any one of claims 13 and 14 wherein said cyanoacrylate composition comprises one or more 2-cyanoacrylate ester monomers wherein said cyanoacrylate ester monomer is an alkyl, cycloalkyl, fluoroalkyl, fluorocycloalkyl or fluoroalkoxy 2-cyanoacrylate monomer.
16. A composition according to claim 14 further comprising at least one thickener selected from the group consisting of poly alkyl-2-cyanoacrylates, poly cycloalkyl-2-cyanoacrylates, poly fluoroalkyl-2-cyanoacrylates, poly fluorocycloalkyl-2-cyanoacrylates, poly alkoxyalkyl-2-cyanoacrylates, poly alkoxycycloalkyl-2-cyanoacrylates, poly fluoroalkoxyalkyl-2-cyanoacrylates, polyalkoxycyclofluoroalkyl-2-cyanoacrylates, poly lactic acid and poly gylcolic acid.
17. A composition according to claim 16 wherein the thickener is a poly alkyl-2- cyanoacrylate.
18. A composition according to claim 17 wherein the alkyl group of the poly alkyl-2- cyanoacrylate is selected from the group consisting of straight chain or branched chain C4 to
C8 hydrocarbons.
19. A composition according to claim 17 wherein the thickener is poly octyl-2- cyanoacrylate.
20. A composition according to claim 13 wherein the 2-cyanoacrylate composition further comprises a stabilizer.
21. A composition according to claim 20 wherein said stabilizer is one or more of an anionic polymerization inhibitor or a free radical polymerization inhibitor.
22. A composition according to claim 13 wherein said cyanoacrylate composition further comprises a plasticizer selected from the group consisting of tributyl acetyl citrate, dimethyl sebacate, diethyl sebacate, triethyl phosphate, tri-(2-ethylhexyl) phosphate, tricresyl phosphate, glycerol triacetate, glycerol tributyrate, dioctyl adipate, isopropyl myristate, butyl stearate, trioctyl trimellitate and dioctyl glutarate.
23. A composition according to claim 22 wherein said plasticizer is up to 50% by weight of the cyanoacrylate composition.
24. A sterile adhesive composition, comprising; at !east one 2-cyanoacrylate monomer and at least one thickener wherein said thickener is selected from the group consisting of poly alkyl-2-cyanoacrylates, poly cycloalkyl-2-cyanoacrylates, poly fluoroalkyl-2- cyanoacrylates, poly fluorocycloaIkyl-2-cyanoacrylates, poly alkoxyalkyl-2- cyanoacrylates, poly alkoxycycloalkyl-2-cyanoacrylates, poly fluoroalkoxyalkyl-2- cyanoacrylates, polyalkoxycylcylofluoroalkyl-2 -cyanoacrylates, poly lactic acid and poly gylcolic acid.
25. An adhesive composition according to claim 24 wherein said thickener is a polyalkyl-
2-cyanoacrylate.
26. An adhesive composition according to claim 25 wherein the alkyl group of the poly alkyl-2-cyanoacrylate is selected from the group consisting of straight chain or branched chain C4 to C8 hydrocarbons.
27. An adhesive composition according to claim 25 wherein said thickener is polyoctyl-2- cyanoacrylate.
28. An adhesive composition according to claim 24 wherein said thickener is present in from about 1% to about 25% by weight of the composition.
29. An adhesive composition according to claim 24 wherein said thickener is present in from about 1% to about 10% by weight of the composition.
30. An adhesive composition according to claim 24 wherein said thickener is present in from about 1% to about 5% by weight of the composition.
31. A method for determining the effectiveness of a sterilization process comprising the steps of; disposing bacterial spores as a biological indicator in a cyanoacrylate composition; exposing the composition to a dry heat sterilization process along with the samples to be sterilized; transferring the cyanoacrylate composition to a sterile aldose solution; transferring and exposing the test sample to a quantity of a nutrient medium which supports germination and growth of any remaining viable spores; incubating the remaining spores and nutrient medium for a period of time to promote the germination and growth of any viable microorganisms; and for the presence or absence of growth of the sample to determine the effectiveness of the sterilization.
32. A method as in claim 31 wherein the cyanoacrylate composition was inoculated with lyophilized spores wherein the spores were selected from the group consisting of Bacillus subtillis and Geobacillus stearothermophillus.
33. A method as in claim 31 wherein bacterial spores were disposed in the cyanoacrylate composition σn any one of a group selected from bacterial spores on a stainless steel disc, bacterial spores on a steel wire, bacterial spores on steel coupons, bacterial spores on borosilicate paper and bacterial spores on woven cotton threads.
34. A method as in claim 31 wherein the aldose solution is selected from the group consisting of aqueous solutions of dextrose, lactose, arabinose, mannose, galactose, rhamnose, fructose, sucrose, and glucose.
35. A method as in claim 34 wherein the aldose is dextrose.
36. A method as in claim 35 wherein the concentration of the dextrose solution is from 2 to 20% by weight.
37. A method as in claim 36 wherein the concentration of the dextrose solution is from about 3% to about 15% by weight.
38. A method as in claim 37 wherein the concentration of the dextrose solution is from about 5% to about 10% by weight.
39. A method as in claim 31 wherein the nutrient medium is Soy-casein digested broth.
40. A method as in claim 31 wherein the samples were incubated at from about 280C to about 370C.
41. A method as in claim 31 wherein the samples were incubated for at least 7 days.
42. A method as in claim 31 wherein bacterial germination and growth was detected by performing a gram stain smear examination of the incubated mixture of cyanoacrylate- sterile dextrose solution.
43. A method as in claim 31 wherein bacterial germination and growth was detected by addition of a Tetrazolium salt indicator followed by UV spectrophotometry analysis.
44. A method as in claim 31 wherein bacterial germination and growth was detected by direct UV spectrophotometry analysis.
PCT/US2005/033226 2004-09-17 2005-09-16 Process for sterilization of and cyanoacrylate adhesive compositions and devices WO2006034064A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05812222A EP1807121A4 (en) 2004-09-17 2005-09-16 Process for sterilization of and cyanoacrylate adhesive compositions and devices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/944,635 2004-09-17
US10/944,635 US8110144B2 (en) 2004-09-17 2004-09-17 Process for sterilization of and cyanoacrylate adhesives compositions and devices

Publications (2)

Publication Number Publication Date
WO2006034064A2 true WO2006034064A2 (en) 2006-03-30
WO2006034064A3 WO2006034064A3 (en) 2006-09-21

Family

ID=36074206

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/033226 WO2006034064A2 (en) 2004-09-17 2005-09-16 Process for sterilization of and cyanoacrylate adhesive compositions and devices

Country Status (3)

Country Link
US (3) US8110144B2 (en)
EP (1) EP1807121A4 (en)
WO (1) WO2006034064A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007046865A1 (en) * 2005-05-24 2007-04-26 Steris, Inc. Biological indicator
WO2019074639A1 (en) * 2017-10-11 2019-04-18 American Sterilizer Company Biological indicator

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006129580A1 (en) * 2005-05-30 2006-12-07 Toagosei Co., Ltd. 2-cyanoacrylate composition
US20080021392A1 (en) * 2006-07-20 2008-01-24 Lurvey Kent L Medical fluid access site with antiseptic indicator
US20080107564A1 (en) 2006-07-20 2008-05-08 Shmuel Sternberg Medical fluid access site with antiseptic indicator
JP5118389B2 (en) * 2007-05-26 2013-01-16 中村製作所株式会社 Method for forming recess in workpiece
US20080311323A1 (en) * 2007-06-12 2008-12-18 Chemence, Inc. Cyanoacrylate Adhesive Compositions and Devices and Process for Sterilization Thereof
US8729121B2 (en) 2007-06-25 2014-05-20 Adhezion Biomedical, Llc Curing accelerator and method of making
USRE47452E1 (en) 2007-07-20 2019-06-25 Baxter International Inc. Antimicrobial housing and cover for a medical device
US9125973B2 (en) 2007-07-20 2015-09-08 Baxter International Inc. Antimicrobial housing and cover for a medical device
AU2008321176A1 (en) * 2007-11-12 2009-05-22 Valor Medical, Inc. Single vial formulation for medical grade cyanoacrylate
WO2009064291A1 (en) * 2007-11-14 2009-05-22 Spartan Medical Products, Llc Cyanoacrylate tissue adhesives
US8198344B2 (en) 2008-06-20 2012-06-12 Adhezion Biomedical, Llc Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
US8293838B2 (en) * 2008-06-20 2012-10-23 Adhezion Biomedical, Llc Stable and sterile tissue adhesive composition with a controlled high viscosity
US20110117047A1 (en) 2008-06-23 2011-05-19 Adhezion Biomedical, Llc Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
EP2346534A1 (en) * 2008-10-17 2011-07-27 3M Innovative Properties Company Sterility indicating biological compositions, articles and methods
US9254133B2 (en) 2008-10-31 2016-02-09 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US8652510B2 (en) 2008-10-31 2014-02-18 Adhezion Biomedical, Llc Sterilized liquid compositions of cyanoacrylate monomer mixtures
US8609128B2 (en) * 2008-10-31 2013-12-17 Adhezion Biomedical, Llc Cyanoacrylate-based liquid microbial sealant drape
WO2010096717A1 (en) 2009-02-20 2010-08-26 Sapheon, Inc. Methods and devices for venous occlusion for the treatment of venous insufficiency
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
US8927603B2 (en) 2010-06-07 2015-01-06 Adhezion Biomedical, Llc X-ray sterilization of liquid adhesive compositions
CN102178978B (en) * 2011-03-18 2013-12-11 广州白云医用胶有限公司 Medical adhesive and preparation method of medical adhesive
WO2013013080A1 (en) 2011-07-20 2013-01-24 Sapheon, Inc. Enhanced ultrasound visualization of intravascular devices
US8808620B1 (en) 2012-02-22 2014-08-19 Sapheon, Inc. Sterilization process design for a medical adhesive
US20140311941A1 (en) 2013-04-19 2014-10-23 Adhezion Biomedical, Llc Package system for sterilizing and storing cyanoacrylate adhesive compositions
US9867973B2 (en) 2013-06-17 2018-01-16 Medline Industries, Inc. Skin antiseptic applicator and methods of making and using the same
US9511156B2 (en) 2014-01-08 2016-12-06 Carefusion 2200, Inc. Systems, methods, and devices for sterilizing antiseptic solutions
US11027032B2 (en) 2014-01-08 2021-06-08 Carefusion 2200, Inc. Systems, methods, and devices for sterilizing antiseptic solutions
US9421297B2 (en) 2014-04-02 2016-08-23 Adhezion Biomedical, Llc Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
US9895455B2 (en) 2015-06-30 2018-02-20 Carefusion 2200, Inc Systems, methods, and devices for sterilizing antiseptic solutions
US10988274B2 (en) 2017-02-07 2021-04-27 Adhezion Biomedical, Llc Packaging for adhesive compositions
CN111458453B (en) * 2020-05-12 2022-07-12 万华化学(四川)有限公司 Method for testing hydroxyl value in lactide-containing polylactic acid and application thereof
US11603551B2 (en) 2020-12-02 2023-03-14 Steritec Products Mfg. Co., Inc. Biological indicators, and systems and methods for determining efficacy of sterilization

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2721858A (en) * 1954-03-10 1955-10-25 Eastman Kodak Co Method of making alpha-cyanoacrylates
US2816093A (en) * 1954-06-02 1957-12-10 Eastman Kodak Co Mixed adhesive compositions including alpha-cyanoacrylate esters
US3178379A (en) * 1961-06-14 1965-04-13 Eastman Kodak Co Method for preparing cyanoacrylate monomer adhesive compositions
SE352812B (en) * 1965-12-09 1973-01-15 Eastman Kodak Co
US3360124A (en) * 1966-05-18 1967-12-26 Ethicon Inc Sterile alkyl ester of 2-cyanoacrylate
US3527841A (en) * 1968-04-10 1970-09-08 Eastman Kodak Co Alpha-cyanoacrylate adhesive compositions
US3654239A (en) * 1970-11-20 1972-04-04 Eastman Kodak Co Process for the preparation of poly-(alpha-cyanoacrylates)
IE35430B1 (en) * 1971-01-06 1976-02-18 Intercontinental Chem Co Ltd High-viscosity cyanoacrylate adhesive compositions and processes for their preparation
US4291122A (en) * 1980-08-14 1981-09-22 American Sterilizer Company Biological indicator for sterilization processes
SE460518B (en) * 1988-02-17 1989-10-23 Diffchamb Ab GEL BODY CONTAINING MICRO-ORGANISMS FOR STERILIZATION CONTROL AND PROCEDURE FOR IMPLEMENTING A STERILIZATION CONTROL
US5252484A (en) * 1988-11-29 1993-10-12 Minnesota Mining And Manufacturing Company Rapid read-out biological indicator
CA2031757A1 (en) 1989-12-14 1991-06-15 George J. Hageage Rapid biological sterility detection method and apparatus therefor
GB9107751D0 (en) * 1991-04-12 1991-05-29 Elopak Systems Treatment of material
KR940002140A (en) * 1992-07-03 1994-02-16 히로세 유끼하루 Low viscosity liquid composite container and its manufacturing method
TW359683B (en) * 1993-12-23 1999-06-01 Loctite Ireland Ltd Sterilized cyanoacrylate adhesive composition, and a method of making such composition
WO1995021936A1 (en) 1994-02-15 1995-08-17 Minnesota Mining And Manufacturing Company Rapid read-out biological indicator
US5795730A (en) * 1995-02-15 1998-08-18 Minnesota Mining And Manufacturing Company Rapid read-out biological indicator
US5928611A (en) * 1995-06-07 1999-07-27 Closure Medical Corporation Impregnated applicator tip
US5981621A (en) * 1996-02-29 1999-11-09 Closure Medical Corporation Monomeric compositions effective as wound closure devices
EP0863994B1 (en) * 1995-07-28 2002-02-20 Minnesota Mining And Manufacturing Company Multi-zone sterility indicator
GB2306469B (en) * 1995-11-02 1998-05-13 Chemence Ltd Sterilising cyanoacrylate preparations
US5770393A (en) * 1997-04-01 1998-06-23 Steris Corporation Biological indicator for detection of early metabolic activity
US6512023B1 (en) * 1998-06-18 2003-01-28 Closure Medical Corporation Stabilized monomer adhesive compositions
GB9820457D0 (en) * 1998-09-18 1998-11-11 Medlogic Global Corp Methods for sterilizing cyanoacrylate compositions
DE69931938T2 (en) 1998-09-18 2007-02-08 Medlogic Global Ltd., Winsford METHOD FOR STERILIZING CYANOACRYLATE MIXTURES
US6451254B1 (en) * 1998-12-30 2002-09-17 Ethicon, Inc. Sterilization of diffusion-restricted area by revaporizing the condensed vapor
US6310166B1 (en) * 1999-08-12 2001-10-30 Closure Medical Corporation Sterilized cyanoacrylate solutions containing thickeners
US6579469B1 (en) * 1999-10-29 2003-06-17 Closure Medical Corporation Cyanoacrylate solutions containing preservatives
US6579916B1 (en) * 2000-11-21 2003-06-17 Medlogic Global Corporation Methods for sterilizing cyanoacrylate compositions
JP2004524291A (en) 2000-11-21 2004-08-12 メドロジック グローバル リミテッド Sterilization method of cyanoacrylate composition
JP3576111B2 (en) * 2001-03-12 2004-10-13 株式会社東芝 Magnetoresistance effect element
US7459142B2 (en) * 2002-06-06 2008-12-02 Micro Therapeutics, Inc. High viscosity embolizing compositions comprising prepolymers
US7371345B2 (en) * 2002-12-23 2008-05-13 Closure Medical Corporation Sterilization of medical adhesive kits
US20050042196A1 (en) * 2003-06-03 2005-02-24 Ian Askill Antimicrobial phenol containing cyanoacrylate compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP1807121A4 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007046865A1 (en) * 2005-05-24 2007-04-26 Steris, Inc. Biological indicator
US7416883B2 (en) 2005-05-24 2008-08-26 Steris Inc. Biological indicator
AU2006302820B2 (en) * 2005-05-24 2010-03-25 American Sterilizer Company Biological indicator
US7741107B2 (en) 2005-05-24 2010-06-22 American Sterilizer Company Biological indicator
US7960169B2 (en) 2005-05-24 2011-06-14 American Sterilizer Company Biological indicator
US8039251B2 (en) 2005-05-24 2011-10-18 American Sterilizer Company Biological indicator
US8084247B2 (en) 2005-05-24 2011-12-27 American Sterilizer Company Biological indicator
WO2019074639A1 (en) * 2017-10-11 2019-04-18 American Sterilizer Company Biological indicator

Also Published As

Publication number Publication date
US8110144B2 (en) 2012-02-07
WO2006034064A3 (en) 2006-09-21
EP1807121A2 (en) 2007-07-18
US20120128903A1 (en) 2012-05-24
US20130011589A1 (en) 2013-01-10
US20130095262A2 (en) 2013-04-18
US20060062687A1 (en) 2006-03-23
EP1807121A4 (en) 2009-04-01

Similar Documents

Publication Publication Date Title
US8110144B2 (en) Process for sterilization of and cyanoacrylate adhesives compositions and devices
US20100213096A1 (en) Cyanoacrylate Adhesive Compositions and Devices and Process for Sterilization Thereof
EP1443973B1 (en) Kits and methods for determining the effectiveness of sterilization or disinfection processes
US20070248486A1 (en) Process for Sterilization of Cyanoacrylate Adhesive Compositions and Devices
US20080311323A1 (en) Cyanoacrylate Adhesive Compositions and Devices and Process for Sterilization Thereof
CA1279245C (en) Method and device for disinfecting biological fluids and container for same
EP0665895B1 (en) Bacillus circulans based biological indicator for gaseous sterilants
US6506416B1 (en) Virucide composition and sporicide composition
Gopal Radiation sterilization of pharmaceuticals and polymers
US6579469B1 (en) Cyanoacrylate solutions containing preservatives
KR20020033080A (en) Biological indicator for sterilization processes with double buffer system
EP1073711B1 (en) Spores with altered resistance to sterilants
JP3987917B2 (en) Rapid readout biological indicator
EP0433053A1 (en) Rapid biological sterility detection method and apparatus therefor
Kearney et al. Evaluation of ethylene oxide sterilization of tissue implants
KR20070087554A (en) Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and hydroxydiphenyl ether
Ogodo et al. Principles of applied microbiology and biotechnology: Technique for the screening of antimicrobial herbs
Mukhopadhayay et al. Sterilization of Biomaterials and Medical Devices with Supercritical CO2
EP4382125A1 (en) Disinfecting composition
US20110028709A1 (en) Methods for sterilizing glucans
WO1995024933A1 (en) Packaging systems for peracid sterilization processes
CN114075560A (en) Stable composition of beta-lactamase
Sultana Sterilization Methods and Principles
KR20060079802A (en) Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone
Pușcaș A new procedure for the rapid determination of Pseudomonas aeruginosa bacteria in medications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005812222

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2005812222

Country of ref document: EP